Does MOTS-c burn belly fat?

I used it during a training block last year. My endurance felt slightly more stable on long rides, but my waist measurement did not budge an inch.

Let us look at the actual biochemistry rather than social media claims. MOTS-c is a mitochondria-derived peptide that activates AMPK, triggering cellular pathways similar to acute exercise and promoting muscle glucose uptake. In rodent studies, it prevents visceral fat storage under high-fat feeding conditions. However, human clinical data remains minimal, safety profiles are unestablished, and WADA strictly bans it under Category S4. It is an indirect metabolic regulator, not a lipolytic agent that targets abdominal fat. Without controlled energy availability, adequate protein, and progressive resistance, it will accomplish very little.

Spot on! Every time someone asks me about belly fat shortcuts, I redirect them to the basics. Sleep quality, daily step counts, and hitting protein goals matter far more for midsection changes than any unproven research peptide.

Sounds like another expensive shortcut. Kettlebell swings and eating real food worked fine before anyone knew what a mitochondrial peptide was.

Messing with metabolic pathways can also trigger transient fatigue or blood sugar drops. If their sleep is wrecked, cortisol is going to keep that belly fat right where it is anyway.

People want a compound to solve an adherence problem. What does their tracking look like over 90 days? Fix the habits before looking at peptides.

In Europe we see similar interest, but patients often ignore that these compounds lack completed human safety trials. Beyond injection site irritation and nausea, altering glucose sensitivity without medical oversight carries real risks, particularly for those on metabolic medications.